Technology
Expansion
Neutral
Croom Medical Achieves Full In-House Production of Patient-Specific Orthopedic Implants, Cutting Lead Time from Weeks to Days
2026-07-08
·
Impact score: 36
Irish orthopedic implant manufacturer Croom Medical now performs the entire in-house manufacturing process for patient-specific implants using titanium, cobalt-chrome, and tantalum, reducing lead time from weeks or months — as seen in traditional multi-supplier models — to just days. By consolidating design, 3D printing, machining, post-processing, and inspection under one roof with a unified quality system, the OEM retains design ownership, Croom Medical manages production, and provides regulatory submission files. Since entering metal additive manufacturing in 2010, the company has developed the TALOS tantalum printing platform and Biofuse lattice technology, and expanded its R&D and industrialization center in February this year. This in-house capability marks a natural extension of its 42-year vertical integration.
📰 News Source
This article was translated from a Chinese source.
Source URL not available
Show Chinese original
Croom Medical实现患者定制骨科植入物全流程内部制造，交付周期从数周缩至数天
爱尔兰骨科植入物制造商Croom Medical现已实现钛、钴铬、钽三种材料的患者定制骨科植入物全流程内部制造，交付周期从传统模式的数周或数月压缩至数天。 传统路径下设计、打印、机加工、后处理与检测分散在不同供应商，各环节交接导致交付周期延长。新模式将所有工序整合至单一厂区，运行统一质量体系，OEM保留设计所有权，Croom Medical负责制造并提供监管申报文件。 公司自2010年进入金属增材制造，拥有TALOS钽打印平台和Biofuse晶格技术，今年2月已扩建研发与工业化中心。 此次内部制造能力落地是其42年来垂直整合的自然延伸。